Pfizer Inc (PFE) 30.18 $PFE
European Stocks Tumble Amid U.S. Clampdown on Tax Inversions
at The Street - 18 mins ago
European stock indices plunge on Tuesday amid profit warnings from high-profile companies and fears that a U.S. clampdown will stem the tide of American deal-making in Europe.
Most active New York Stock Exchange-traded stocks
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Pfizer (PFE) Approaches New Downside Target of $29.92
Comtex SmarTrend(R) - Mon Sep 22, 10:40AM CDT
Shares of Pfizer (NYSE
FE) opened today below their pivot of $30.50 and have already reached the first level of support at $30.16. Analysts will be watching for a cross of the next downside pivot targets of $29.92 and $29.34.
Early Glance: Pharmaceuticals companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
PR Newswire - Mon Sep 22, 8:05AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) and Endo International plc (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6643-100free.
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations
Business Wire - Mon Sep 22, 7:01AM CDT
Circle Pharma, Inc., a newly created, early-stage biotechnology company, today announced that it has received seed funding from Pfizer Inc. and QB3's seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer to develop cell permeable macrocyclic peptide therapeutics.
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Business Wire - Mon Sep 22, 7:00AM CDT
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced charitable donations totaling more than $1 million to be granted between 2014 and 2016 to seven nonprofit organizations that support patients with cardiovascular disease. The donations will fund the independent development of innovative educational materials about stroke risk reduction in patients with nonvalvular atrial fibrillation (NVAF). The materials, accessible to both patients and caregivers, will address disease awareness, identification of signs and symptoms, access to care, appropriate treatment options, shared decision making and medication adherence. National Stroke Association, Heart Rhythm Society, American College of Physicians, American Heart Association Founders Affiliate, Regents of the University of Michigan/Society for Vascular Medicine, WomenHeart and American College of Emergency Physicians will each receive a charitable donation to support their independent educational initiatives.
Breast Cancer Occurs Most Often in These 5 States
Sean Williams, The Motley Fool - Motley Fool - Sun Sep 21, 8:21AM CDT
Source: Flickr user Paul Falardeau. With the exception of certain types of skin cancers, breast cancer is the most commonly diagnosed cancer in women. Though the disease is by no means relegated just to women -- more than 2,000 cases were...
Stock Market News for September 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 9:10AM CDT
Benchmarks settled in the green on Thursday a day after Fed’s pledge to keep short-term interest rates near zero for a “considerable time”
Pfizer Foundation Provides $2 Million In Grants To Support 'Last-Mile' Vaccine Coverage In Africa
Business Wire - Fri Sep 19, 7:00AM CDT
--Programs designed to reach children in remote locations in five African countries.
Market Maker Surveillance Report. GM, KO, PFE, BAC, MS, VZ, Bullishly Biased Price Friction For Thursday, September 18th 2014
M2 - Fri Sep 19, 4:02AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4944 companies with "abnormal" market making, 2520 companies with positive Friction Factors and 2350 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. General Motors Co (NYSE:GM), The Coca-Cola Co (NYSE:KO), Pfizer Inc (NYSE FE), BANK OF AMERICA CORPORATION (NYSE:BAC), Morgan Stanley (NYSE:MS), Verizon Communications Inc (NYSE:VZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 3:55PM CDT
Merck & Co., Inc., (MRK) entered into a worldwide licensing agreement with Sun Pharmaceutical Industries Ltd.
European Stocks Tumble Amid U.S. Clampdown on Tax Inversions
at The Street - 18 mins ago
European stock indices plunge on Tuesday amid profit warnings from high-profile companies and fears that a U.S. clampdown will stem the tide of American deal-making in Europe.
Most active New York Stock Exchange-traded stocks
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Pfizer (PFE) Approaches New Downside Target of $29.92
Comtex SmarTrend(R) - Mon Sep 22, 10:40AM CDT
Shares of Pfizer (NYSE
FE) opened today below their pivot of $30.50 and have already reached the first level of support at $30.16. Analysts will be watching for a cross of the next downside pivot targets of $29.92 and $29.34. Early Glance: Pharmaceuticals companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
PR Newswire - Mon Sep 22, 8:05AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) and Endo International plc (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6643-100free.
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations
Business Wire - Mon Sep 22, 7:01AM CDT
Circle Pharma, Inc., a newly created, early-stage biotechnology company, today announced that it has received seed funding from Pfizer Inc. and QB3's seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer to develop cell permeable macrocyclic peptide therapeutics.
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Business Wire - Mon Sep 22, 7:00AM CDT
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced charitable donations totaling more than $1 million to be granted between 2014 and 2016 to seven nonprofit organizations that support patients with cardiovascular disease. The donations will fund the independent development of innovative educational materials about stroke risk reduction in patients with nonvalvular atrial fibrillation (NVAF). The materials, accessible to both patients and caregivers, will address disease awareness, identification of signs and symptoms, access to care, appropriate treatment options, shared decision making and medication adherence. National Stroke Association, Heart Rhythm Society, American College of Physicians, American Heart Association Founders Affiliate, Regents of the University of Michigan/Society for Vascular Medicine, WomenHeart and American College of Emergency Physicians will each receive a charitable donation to support their independent educational initiatives.
Breast Cancer Occurs Most Often in These 5 States
Sean Williams, The Motley Fool - Motley Fool - Sun Sep 21, 8:21AM CDT
Source: Flickr user Paul Falardeau. With the exception of certain types of skin cancers, breast cancer is the most commonly diagnosed cancer in women. Though the disease is by no means relegated just to women -- more than 2,000 cases were...
Stock Market News for September 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 9:10AM CDT
Benchmarks settled in the green on Thursday a day after Fed’s pledge to keep short-term interest rates near zero for a “considerable time”
Pfizer Foundation Provides $2 Million In Grants To Support 'Last-Mile' Vaccine Coverage In Africa
Business Wire - Fri Sep 19, 7:00AM CDT
--Programs designed to reach children in remote locations in five African countries.
Market Maker Surveillance Report. GM, KO, PFE, BAC, MS, VZ, Bullishly Biased Price Friction For Thursday, September 18th 2014
M2 - Fri Sep 19, 4:02AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4944 companies with "abnormal" market making, 2520 companies with positive Friction Factors and 2350 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. General Motors Co (NYSE:GM), The Coca-Cola Co (NYSE:KO), Pfizer Inc (NYSE
FE), BANK OF AMERICA CORPORATION (NYSE:BAC), Morgan Stanley (NYSE:MS), Verizon Communications Inc (NYSE:VZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 3:55PM CDT
Merck & Co., Inc., (MRK) entered into a worldwide licensing agreement with Sun Pharmaceutical Industries Ltd.
